105 related articles for article (PubMed ID: 338514)
1. Circulating immune complexes in patients with malignant lymphomas and solid tumors.
Heier HE; Carpentier N; Lange G; Lambert PH; Godal T
Int J Cancer; 1977 Dec; 20(6):887-94. PubMed ID: 338514
[TBL] [Abstract][Full Text] [Related]
2. The C1q binding test for soluble immune complexes: clinical correlations obtained in patients with cancer.
Rossen RD; Reisberg MA; Hersh EM; Gutterman JU
J Natl Cancer Inst; 1977 May; 58(5):1205-15. PubMed ID: 323505
[TBL] [Abstract][Full Text] [Related]
3. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
[TBL] [Abstract][Full Text] [Related]
4. Relationship between renal pathology and the size of circulating immune complexes in patients with systemic lupus erythematosus.
Wener MH; Mannik M; Schwartz MM; Lewis EJ
Medicine (Baltimore); 1987 Mar; 66(2):85-97. PubMed ID: 3102894
[TBL] [Abstract][Full Text] [Related]
5. A comparison of two 125I C1q binding tests to detect soluble immune complexes in serum of patients with malignant disease.
Shepherd PS
Clin Exp Immunol; 1979 May; 36(2):250-5. PubMed ID: 477028
[TBL] [Abstract][Full Text] [Related]
6. Circulating immune complexes and prognosis in human malignant lymphoma, a prospective study.
Heier HE; Landaas TO; Marton PF
Int J Cancer; 1979 Mar; 23(3):292-8. PubMed ID: 437911
[TBL] [Abstract][Full Text] [Related]
7. Reaction of immune complexes with Hodgkin's disease tissue cultures: radioimmune assay and immunoferritin electron microscopy.
Long JC; Dvorak AM; Quay SC; Stamatos C; Chi SY
J Natl Cancer Inst; 1979 Apr; 62(4):787-97. PubMed ID: 372654
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of circulating immune complexes in lymphomas and leukemias using two different assays.
Patel GV; Gopal R; Nadkarni JJ
Cancer Immunol Immunother; 1985; 20(1):80-4. PubMed ID: 3877562
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of serum complement components and plasma C3d in patients with malignant lymphoma: relation to the stage of the tumor and circulating immune complexes.
Heier HE; Carpentier NA; Lambert PH; Godal T
Int J Cancer; 1978 Jun; 21(6):695-9. PubMed ID: 669852
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of circulating immune complexes in human leukemia. Association in acute leukemia of the presence of immune complexes with unfavorable prognosis.
Carpentier NA; Lange GT; Fiere DM; Fournie GJ; Lambert PH; Miescher PA
J Clin Invest; 1977 Oct; 60(4):874-84. PubMed ID: 268330
[TBL] [Abstract][Full Text] [Related]
11. [Immunologic study of pleural neoplastic effusions: Detection of immune complexes and complement activation].
Kaelin R; Docquier C; Lew D; Carpentier N; Lambert PH; Waldvogel FA
Schweiz Med Wochenschr; 1978 Dec; 108(49):1971-3. PubMed ID: 749195
[TBL] [Abstract][Full Text] [Related]
12. The effect of age on the character of immune complex disease: a comparison of the incidence and relative size of materials reactive with Clq in sera of patients with glomerulonephritis and cancer.
Rossen RD; Reisberg MA; Singer D; Suki WN; Duffy J; Hersh EM; Schloeder FX; Hill LL; Eknoyan G
Medicine (Baltimore); 1979 Jan; 58(1):65-79. PubMed ID: 154003
[TBL] [Abstract][Full Text] [Related]
13. [Levels of immune complexes in fresh and frozen serum and plasma detected by precipitation with polyethylene glycol in patients with malignant diseases].
Kovcin V; Juranić Z; Babović N; Tomasević Z
Srp Arh Celok Lek; 1997; 125(5-6):154-6. PubMed ID: 9265236
[TBL] [Abstract][Full Text] [Related]
14. [Circulating immune complexes of patients with malignant lymphomas (author's transl)].
Sodomann CP; Schmidt H; Havemann K
Blut; 1979 Jun; 38(6):435-46. PubMed ID: 444682
[TBL] [Abstract][Full Text] [Related]
15. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.
Nydegger UE; Lambert PH; Gerber H; Miescher PA
J Clin Invest; 1974 Aug; 54(2):297-309. PubMed ID: 4847246
[TBL] [Abstract][Full Text] [Related]
16. Immune complexes in Hodgkin's disease: isolation, immunochemical and physico-chemical analysis.
Kilgallon W; Amlot PL; Williams BD
Clin Exp Immunol; 1983 Aug; 53(2):308-18. PubMed ID: 6411401
[TBL] [Abstract][Full Text] [Related]
17. Purification of soluble immune complexes from serum using polymethylmetacrylate beads coated with conglutinin or C1q. Application to the analysis of the components of in vitro formed immune complexes and of immune complexes occurring in vivo during leishmaniasis.
Casali P; Lambert PH
Clin Exp Immunol; 1979 Aug; 37(2):295-309. PubMed ID: 498587
[TBL] [Abstract][Full Text] [Related]
18. Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients.
Teshima H; Wanebo H; Pinsky C; Day NK
J Clin Invest; 1977 Jun; 59(6):1134-42. PubMed ID: 325016
[TBL] [Abstract][Full Text] [Related]
19. Biochemical classification of circulating immune complexes in human malignant melanoma and hematologic neoplasms.
Queen WD; Bharwani N; Phillips EA; Ruether BA; Phillips TM; Jerry LM
Oncology; 1989; 46(1):14-25. PubMed ID: 2915889
[TBL] [Abstract][Full Text] [Related]
20. Selective losses of large immune complexes during density gradient ultracentrifugation and an approach for prevention of these losses.
Wener MH; Mannik M
J Immunol Methods; 1985 Nov; 84(1-2):1-10. PubMed ID: 3877767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
